Lithium Nursing Considerations and Patient Teaching

In short: lithium is a mood stabiliser for bipolar disorder with a narrow margin between a therapeutic and a toxic serum level. The nursing considerations are: monitor serum lithium levels on schedule (drawn as trough levels before the next dose) and whenever toxicity is suspected, together with renal and thyroid function; recognise early toxicity — diarrhoea, vomiting, coarse tremor, drowsiness, muscle weakness, ataxia — and respond by holding the dose, obtaining a level and notifying the prescriber; protect fluid and sodium balance, because dehydration, low-salt diets, sweating, GI illness and drugs such as NSAIDs, ACE inhibitors and diuretics raise the level; and teach the patient to keep intake steady, never double a missed dose, report illness or new medicines, and keep every blood-test appointment.

Why lithium is used

Lithium is a mood stabiliser used in bipolar disorder for acute manic episodes and for long-term prevention of relapse. The National Institute of Mental Health also notes that lithium can decrease the risk of suicide, which is one reason adherence teaching matters beyond symptom control. Its clinical context — recognising mania, the priorities in an acute episode and relapse prevention — is covered in mania nursing interventions and, across all phases of the illness, in bipolar disorder nursing care.

Why lithium needs this much attention

Lithium is handled by the body like sodium: filtered by the kidneys and reabsorbed alongside sodium. That single fact explains most of the nursing considerations. Anything that makes the kidneys hold on to sodium — dehydration, a low-sodium diet, heavy sweating, vomiting, diarrhoea, certain diuretics and other medicines — makes them hold on to lithium too, and the level rises without the dose changing. The prescribing information describes it plainly: sodium loss may reduce the renal clearance of lithium and increase serum lithium levels, and it is essential for the patient to maintain a normal diet, including salt, and adequate fluid intake.

Nursing assessment

Before a dose and at every contact, the nurse assesses the things that predict a rising level and the things that show one:

• Intake and losses: fluids and food in the last day; vomiting, diarrhoea, fever, heavy sweating, unusual exercise, a new low-salt diet.
• Medicines: anything new or stopped since the last level — particularly pain relievers, blood-pressure medicines and diuretics.
• Toxicity cues: GI symptoms, quality of tremor (fine and stable is expected; coarse, new or worsening is a warning), gait, speech, alertness.
• Expected effects: fine hand tremor, increased thirst and urination, mild nausea early in treatment, weight gain — managed and taught, not alarming on their own.
• Mood and safety: the underlying bipolar disorder still needs assessment; see suicide risk assessment.

Monitoring

Serum lithium levels

Levels are drawn frequently when treatment starts or the dose changes, periodically once stable, and immediately whenever toxicity is suspected. Timing matters for interpretation: the prescribing information specifies that samples are drawn immediately before the next dose, when concentrations are relatively stable — roughly 8 to 12 hours after the previous dose. A level drawn shortly after a dose reads high and can mislead. Treat the exact therapeutic and toxic ranges as reference values to confirm in your current source, not numbers to memorise from a website; the exam tests whether you recognise toxicity and act, not whether you can quote decimals.

Organ function and other checks

Baseline and periodic renal function and thyroid function are standard: lithium is renally cleared, long-term therapy can reduce the kidney's concentrating ability, and hypothyroidism can develop during treatment. Electrolytes, calcium and an ECG may be ordered depending on the patient's risk. Pregnancy status matters before starting — the prescribing information notes an association with cardiac and other anomalies — so contraception and pregnancy planning are part of the conversation with the prescriber.

Lithium toxicity symptoms: early, advancing and severe

Lithium toxicity symptoms progress from gastrointestinal to neurological to cardiovascular. The nursing rule is the same at every stage — hold the dose, obtain a level as ordered, notify the prescriber — with the urgency rising as neurological signs appear. Memorise the early cluster, because it is the one patients and nurses see first: diarrhoea, vomiting, a coarse (not fine) hand tremor, drowsiness, muscle weakness and unsteadiness.

The prescribing information itself instructs the patient to stop lithium and contact the prescriber if diarrhoea, vomiting, tremor, mild ataxia, drowsiness or muscle weakness occur — the early list is the one patients are taught to act on.

Interactions to flag

The nurse does not manage interactions alone, but must recognise which new prescriptions or over-the-counter products need the prescriber's attention. The prescribing information identifies non-steroidal anti-inflammatory drugs (indomethacin and piroxicam are named as significantly increasing steady-state lithium concentrations, with other NSAIDs suspected), ACE inhibitors and diuretics as raising lithium levels through effects on sodium and renal clearance. In practice: any new pain reliever, blood-pressure medicine or "water tablet" in a patient on lithium is a reason to contact the prescriber and consider a level. Confirm the full interaction list in a current reference.

When findings require escalation

Patient teaching

• Take lithium exactly as prescribed; never double up after a missed dose.
• Keep fluid intake and salt intake steady day to day; do not start a low-salt diet, a crash diet or a sudden intensive exercise programme without discussing it.
• Report vomiting, diarrhoea, fever or any illness that reduces intake — the level may need checking, and the prescriber may adjust the dose.
• Tell every prescriber, dentist and pharmacist you take lithium; ask before taking any pain reliever or new medicine, including over-the-counter products.
• Know the early toxicity signs and what to do about them: stop, and call.
• Attend every blood-test appointment, and have levels drawn before the morning dose as instructed.
• Benefit builds over days to weeks; keep taking lithium when mood is stable — stopping is the commonest route to relapse.
• Discuss contraception and pregnancy planning with the prescriber.

Clinical judgment: the summer-heat scenario

A patient stable on lithium for months comes to clinic in a heatwave reporting two days of diarrhoea, a shaky hand and feeling "off". Cues: fluid loss, coarse tremor, malaise. Analysis: likely rising lithium level from dehydration. Priority: possible toxicity. Action: hold the next dose pending a level, notify the prescriber, assess hydration and vital signs. Evaluate: level result and symptom trend. The trap answer is "reassure the patient that a tremor is a normal side effect".

High-yield exam priorities

• Hold, level, notify — the response to any toxicity cue.
• Sodium down, lithium up: dehydration, low salt, GI loss, sweating, diuretics.
• Fine tremor expected; coarse tremor a warning.
• Neurological signs mean advancing toxicity — urgent.
• Levels are trough levels, drawn before the dose.
• Renal and thyroid monitoring; pregnancy planning.
• NSAIDs, ACE inhibitors and diuretics are the interaction classes to recognise.

Test yourself

Key takeaways

• Lithium's narrow therapeutic range makes monitoring the treatment, not an add-on.
• Sodium and water losses raise lithium levels: dehydration, low-salt diets, GI illness, sweating, and NSAIDs, ACE inhibitors and diuretics.
• Early toxicity looks like GI upset plus coarse tremor; advancing toxicity looks neurological.
• Hold, level, notify — then teach so the patient can protect themselves at home.

Verification note. Specific therapeutic and toxic serum ranges, monitoring intervals and dose adjustments are set by the current prescribing information and your facility's protocol and are intentionally not stated here. Facts attributed to "the prescribing information" above were checked against the FDA-approved lithium carbonate labeling on DailyMed on the build date.

Verified references

Authoritative sources reviewed for this article. They are linked for further reading; the nursing guidance above is educational and your program's current references and facility protocols take precedence.

1. Lithium carbonate capsules — current prescribing information (boxed warning, monitoring, interactions) — DailyMed, U.S. National Library of Medicine (FDA-approved labeling)
2. Lithium — drug information — MedlinePlus, U.S. National Library of Medicine (NIH)
3. Bipolar Disorder — NIMH brochure (episodes, mood stabilisers) — National Institute of Mental Health (NIMH)
4. Bipolar disorder: assessment and management (CG185) — National Institute for Health and Care Excellence (NICE)